日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative Effectiveness of Fumarates Versus Sphingosine-1-Phosphate Receptor Modulators in Black Patients with Multiple Sclerosis

富马酸盐与鞘氨醇-1-磷酸受体调节剂在黑人多发性硬化症患者中的疗效比较

Woodson, Sophia; Gettings, Edward J; Guo, Chu-Yueh; Klineova, Sylvia; Lee, Jong-Mi; Romero, Rebecca S; Walker, Aljoeson; Belviso, Nicholas; Shankar, Sai L; Mendoza, Jason P; Bian, Boyang; Lewin, James B; Fong, Kinyee

Real-World Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates in the USA

美国使用富马酸盐治疗多发性硬化症的黑人、西班牙裔、亚裔和白人患者的真实世界治疗结果

Woodson, Sophia; Gettings, Edward J; Guo, Chu-Yueh; Klineova, Sylvia; Lee, Jong-Mi; Romero, Rebecca S; Walker, Aljoeson; Fong, Kinyee; Mendoza, Jason P; Belviso, Nicholas; Bian, Boyang; Lewin, James B; Shankar, Sai L

Real-World Treatment Outcomes in Black, Hispanic, Asian, and White Patients with Multiple Sclerosis Treated with Natalizumab

纳他珠单抗治疗多发性硬化症黑人、西班牙裔、亚裔和白人患者的真实世界治疗结果

Blitz-Shabbir, Karen; Banks, Aimee M; Garg, Hina; Nelson, Flavia; Shah, Suma; Belviso, Nicholas; Mendoza, Jason P; Avila, Robin L; Bian, Boyang; Fong, Kinyee